CD4 and pneumocystosis: In the study by Mansharamani et al, their proposed cut off of <300 CD4+ cells/mm3 would capture 91% of cases of PCP in all HIV negative patients, but would also include 39–46% of patients on systemic steroids, most of whom would be unaffected by PCP.